Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series
November 17, 2023Time
11:00 am - 12:00 pm America/Chicago
More than one million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020 (Office of Inspector General). However, fewer than one in five Medicare beneficiaries with an opioid use disorder (OUD) diagnosis received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care (Klimas J, Hamilton M, et al., 2021). This no-cost learning series is a collaboration of Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs). Subject matter experts will provide strategies, interventions and targeted solutions ensuring access to MOUD treatment and facilitating the continuity of care through the continuum. Join us virtually one Friday each month, September 2023 – June 2024 at 11 a.m. CT.
A general certificate of attendance will be provided for continuing education/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification within their discipline.
For questions about the series contact: QIconnect@telligen.com
Dates & Topics:
Registration Required: Register here.
*After the event, you can request presentation slides and other resources by emailing QIConnect@telligen.com.